BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18506854)

  • 1. Proteasome activation as a novel antiaging strategy.
    Chondrogianni N; Gonos ES
    IUBMB Life; 2008 Oct; 60(10):651-5. PubMed ID: 18506854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome dysfunction in mammalian aging: steps and factors involved.
    Chondrogianni N; Gonos ES
    Exp Gerontol; 2005 Dec; 40(12):931-8. PubMed ID: 16246514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome function determines cellular homeostasis and the rate of aging.
    Chondrogianni N; Gonos ES
    Adv Exp Med Biol; 2010; 694():38-46. PubMed ID: 20886755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteasome and proteolysis].
    Papapostolou D; Reboud-Ravaux M
    J Soc Biol; 2004; 198(3):263-78. PubMed ID: 15662944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ubiquitin-proteasome system in ageing.
    Löw P
    Gen Comp Endocrinol; 2011 May; 172(1):39-43. PubMed ID: 21324320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteasome and its role in nuclear protein maintenance.
    Bader N; Jung T; Grune T
    Exp Gerontol; 2007 Sep; 42(9):864-70. PubMed ID: 17532163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ageing and rejuvenating effects of quercetin.
    Chondrogianni N; Kapeta S; Chinou I; Vassilatou K; Papassideri I; Gonos ES
    Exp Gerontol; 2010 Oct; 45(10):763-71. PubMed ID: 20619334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of the proteasomal system during the aging process.
    Baraibar MA; Friguet B
    Prog Mol Biol Transl Sci; 2012; 109():249-75. PubMed ID: 22727424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of proteasome-mediated protein degradation during oxidative stress and aging.
    Breusing N; Grune T
    Biol Chem; 2008 Mar; 389(3):203-9. PubMed ID: 18208355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of donor age on proteasome activity and senescence in trabecular meshwork cells.
    Caballero M; Liton PB; Challa P; Epstein DL; Gonzalez P
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1048-54. PubMed ID: 15381105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative protein damage and the proteasome.
    Grimm S; Höhn A; Grune T
    Amino Acids; 2012 Jan; 42(1):23-38. PubMed ID: 20556625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status.
    Chondrogianni N; Trougakos IP; Kletsas D; Chen QM; Gonos ES
    Aging Cell; 2008 Oct; 7(5):717-32. PubMed ID: 18691182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein oxidation and proteolysis.
    Bader N; Grune T
    Biol Chem; 2006; 387(10-11):1351-5. PubMed ID: 17081106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage-displayed antibodies for the detection of glycated proteasome in aging cells.
    Gonzalez-Dosal R; Sørensen MD; Clark BF; Rattan SI; Kristensen P
    Ann N Y Acad Sci; 2006 May; 1067():474-8. PubMed ID: 16804029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The olive constituent oleuropein exhibits proteasome stimulatory properties in vitro and confers life span extension of human embryonic fibroblasts.
    Katsiki M; Chondrogianni N; Chinou I; Rivett AJ; Gonos ES
    Rejuvenation Res; 2007 Jun; 10(2):157-72. PubMed ID: 17518699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the control of intracellular protein turnover: mitochondrial Lon protease inhibitors versus proteasome inhibitors.
    Bayot A; Basse N; Lee I; Gareil M; Pirotte B; Bulteau AL; Friguet B; Reboud-Ravaux M
    Biochimie; 2008 Feb; 90(2):260-9. PubMed ID: 18021745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteasomal system.
    Jung T; Catalgol B; Grune T
    Mol Aspects Med; 2009 Aug; 30(4):191-296. PubMed ID: 19371762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TROSY-based NMR evidence for a novel class of 20S proteasome inhibitors.
    Sprangers R; Li X; Mao X; Rubinstein JL; Schimmer AD; Kay LE
    Biochemistry; 2008 Jul; 47(26):6727-34. PubMed ID: 18540636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein silencing switch by ligand-induced proteasome-targeting intrabodies.
    Melchionna T; Cattaneo A
    J Mol Biol; 2007 Nov; 374(3):641-54. PubMed ID: 17950312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein degradation and aging.
    Martinez-Vicente M; Sovak G; Cuervo AM
    Exp Gerontol; 2005; 40(8-9):622-33. PubMed ID: 16125351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.